Melatonin and Retinoic Acid Induce Apoptosis in Breast Cancer Cells
Author Information
Author(s): KM Eck, L Yuan, L Duffy, PT Ram, S Ayettey, I Chen, CS Cohn, JC Reed, SM Hill
Primary Institution: Tulane University School of Medicine
Hypothesis
Does a sequential treatment regimen with melatonin and all-trans retinoic acid induce apoptosis in MCF-7 tumor cells?
Conclusion
The sequential treatment with melatonin followed by all-trans retinoic acid effectively induces apoptosis in hormone-responsive breast cancer cells.
Supporting Evidence
- The sequential treatment resulted in a complete cessation of cell growth in MCF-7 cells.
- Apoptosis was evidenced by morphological changes and increased expression of pro-apoptotic factors.
- ER-negative breast cancer cells did not respond to the sequential treatment.
Takeaway
This study found that giving melatonin and retinoic acid one after the other can help kill certain breast cancer cells.
Methodology
The study used MCF-7 and T47D breast cancer cell lines to test the effects of melatonin and retinoic acid on cell proliferation and apoptosis.
Limitations
The study was conducted only in cultured cells, and results may differ in human tumors.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website